The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolismWhitney S. Thompson, Joseph B. Lillegard, Gourish Mondal et al.|Expert Opinion on Orphan Drugs|2020Cited by 14
Activation of homology-directed DNA repair plays key role in CRISPR-mediated genome correctionGourish Mondal, Joseph B. Lillegard, Caitlin J. VanLith et al.|Gene Therapy|2022Cited by 3
Ectopic hepatocyte transplantation cures the pig model of tyrosinemiaClara T. Nicolas, Joseph B. Lillegard|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1